At Bicycle Health, research is at the core of our science-informed treatment. We aim to expand access to biopsychosocial treatment of opioid use disorder (OUD) via telehealth.

See our papers

Peer Reviewed Papers on the Bicycle Health Model

Perspectives of Patients Receiving Telemedicine Services for Opioid Use Disorder Treatment: A Qualitative Analysis of User Experiences

Researchers from RAND Corporation conducted 20 qualitative interviews with Bicycle Health patients about their experiences with tele-OUD treatment. Overall, patients described increased patient-centeredness as an advantage of tele-OUD and felt it helped to ameliorate social barriers to seeking treatment, as well as high satisfaction rates with plans to continue using tele-OUD for at least six months. Nearly all patients rated their satisfaction with the tele-OUD service as a “4” or “5” on a scale of 1-5. These findings are consistent with literature that suggests that fully virtual models of tele-OUD treatment have the potential to increase access to medication for opioid use disorder and improve the patient experience.
Read the Paper

Patient-centered, tech-enabled care model for opioid use disorder via telehealth

The Bicycle Health clinical model of collaborative, integrated medical and behavioral health care that delivers biopsychosocial treatment of opioid use disorder (OUD) via telehealth is an effective way to reach previously unengaged and unreached populations, as evidenced by 31% of Bicycle Health patients reporting no previous history of buprenorphine treatment. Other benefits of the model include retention rates – 86% for insured patients at 30 days and 75% for a mixed population of insured and self pay at 30 days – and accessibility, with 70% of new patients being seen by a buprenorphine-waivered provider on the same or next business day as their initial enrollment outreach.

Rollston R, et al. A Collaborative, Patient-Centered Care Model that Provides Tech-Enabled Treatment of Opioid Use Disorder via Telehealth. BMJ. 2022.
Read the Paper

Imagine what’s possible on the other side of opioid use disorder.

Our science-backed approach boasts 95% of patients reporting no withdrawal symptoms at 7 days. We can help you achieve easier days and a happier future.

Get Startedor book an enrollment call